Thanks to its ease of use, modularity, and scalability, the clustered regularly interspaced short palindromic repeats (CRISPR) system has been increasingly used in the design and engineering of Saccharomyces cerevisiae, one of the most popular hosts for industrial biotechnology. This review summarizes the recent development of this disruptive technology for metabolic engineering applications, including CRISPR-mediated gene knock-out and knock-in as well as transcriptional activation and interference. More importantly, multi-functional CRISPR systems that combine both gain-and loss-of-function modulations for combinatorial metabolic engineering are highlighted.
Introduction
There is a growing interest in sustainable production of fuels, chemicals, and pharmaceutics using microbial cell factories. Since microorganisms are not evolved to produce desired products, their metabolic and regulatory networks must be intensively rewired using metabolic engineering approaches to maximize titers, yields, and productivities for commercially viable processes. Saccharomyces cerevisiae is one of the most prominent cell factories for industrial applications, thanks to its numerous advantages such as the generally recognized as safe (GRAS) status, availability of ample genetic tools, compatibility of high-density and large-scale fermentation, resistance to phage infection, and high tolerance against toxic inhibitors and final products [1] [2] [3] . Metabolic engineering has enabled the construction and optimization of yeast cell factories to convert various substrates to a wide variety of products ranging from fuels and chemicals to drugs. However, it is a time-consuming and laborious process to engineer a recombinant yeast strain for industrial applications, since extensive multi-step metabolic engineering efforts are required to develop and optimize cell factories [4] [5] [6] [7] .
Metabolic engineering generally involves increasing the expression of some genes encoding rate-limiting enzymes, decreasing the expression of some essential genes, and removing the expression of some competing pathways, as well as introducing novel biosynthetic pathways [8] . In other words, one determinant for successful metabolic engineering is the ability to manipulate the host genome. Although homologous recombination based gene replacement has been used for genome engineering of yeast for decades, it is slow, inefficient, labor-intensive, and of low throughput. Therefore, it is essential to develop novel genome engineering tools that are modular and scalable.
The recently developed clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated (Cas) system is widely considered as a disruptive technology to revolutionize metabolic engineering. In this system, a guide RNA (gRNA) recruits a CRISPR nuclease (i.e. Cas9) to a specific region of the genome, resulting in a double-strand break at that specific site [9] [10] [11] [12] . The desired genome modification (i.e. gene deletion or integration) can be achieved by homology directed repair (HDR) in S. cerevisiae (Fig. 1A) . By mutating the HNH nuclease domain (H840A) and RuvC-like domain (D10A), dCas9 (dead Cas9 or nuclease-deficient Cas9) can still bind to the target region, but without introducing a double-strand break. In this case, transcriptional activation or interference can be achieved by recruiting an activator or repressor domain to the nuclease-deficient CRISPR complex (Fig. 1B ) [13] [14] [15] [16] . In other words, the CRISPR system has been demonstrated the capability of gene deletion, gene integration, transcriptional activation (CRISPRa), and transcriptional interference (CRISPRi), which represent most of the genetic manipulations needed for metabolic engineering.
This review covers the most recent advances in the development and application of the CRISPR/Cas system for metabolic engineering of yeast cell factories. Since metabolic engineering involves multi-mode modulation of multiple targets [8] , we focus on CRISPR mediated multiplex genome engineering and development of multi-functional CRISPR systems, which allows combinatorial optimization of both gain-of-function and loss-of-function modifications.
CRISPR for genome editing
HDR is a preferred error-free DNA repair mechanism for yeast genome engineering.
Although robust, the natural HDR is still not efficient enough and selection is required to obtain correct clones. Since the DNA double-strand break induced by the CRISPR system is lethal, HDR serves as the positive selection and marker-free genome editing is possible [17] . Based on the HDR donors provided, gene disruption (Fig. 1C) , gene deletion ( Fig. 1D ), gene integration ( Fig. 1E ), simultaneous gene deletion and integration (Fig. 1F) , and gene deletion and gene integration as well as DNA assembly (Fig. 1G ) can be achieved, respectively. Readers of interest are directed to recent reviews on the design of CRISPR system parameters and the corresponding genome editing efficiencies [18, 19] .
CRISPR mediated gene knock-out
Thanks to the convenience and significantly reduced cost of DNA synthesis, customized double-strand oligonucleotides (dsOligo) including homology arms to the target site and an internal stop codon or frame-shift deletion are commonly used as the template for HDR. DiCarlo et al. reported for the first time to adopt CRISPR/Cas for gene knock-out in yeast ( Fig. 1C and 1D ).
With a 90-bp dsOligo as the HDR template, 100% knock-out efficiency of the CAN1 gene was achieved without selection [17] . Similarly, Ryan et al. used 120-bp barcoded dsOligo with a TAA stop codon as templates for the marker-free disruption of 11 individual genes (URA3, QCR9,   QCR6, COX10, HIS2, ARG80, TRP1, CAN1, MET6, LEU2 , and LYP1), all with knock-out efficiencies close to 100% [20] .
Encouraged by the flexibility and high efficiency of CRISPR/Cas, Jakociunas et al.
attempted multiplex gene knock-out in yeast, with the construction of a mevalonate (a key precursor metabolite for isoprenoid production) overproducing yeast strain as a case study [21] .
Based on previous studies, four genes were selected for knock-out (BTS1, ROX1, YPL062W, and YJL064W) and one essential gene (ERG9) for knock-down. For each knock-out target, a 90-bp dsOligo was used for HDR. To down-regulate ERG9 expression, a 300-bp dsOligo without an upstream activating sequence (lowering transcription) was used to replace the native promoter. By co-transforming the gRNA plasmids and the corresponding linear HDR donors, 50-100%   efficiency was achieved for all single, double, triple, quadruple and quintuple edits, and the best performing strain accumulated 41-fold more mevalonate than the wild-type [21] . Mans et al. also
reported multiplex gene knock-out using 120-bp dsOligo for HDR: when four genes (MCH1, MCH2, ITR1, and PDR12) were targeted with two dual-gRNA plasmids, 75% deletion efficiency was achieved; when six genes (MCH1, MCH2, ITR1, PDR12, MCH5, and AQY1) with three dualgRNA plasmids, 65% deletion efficiency was achieved simultaneously [22] .
The desired genome editing is possible only when the gRNA plasmids and the corresponding HDR donors are transformed to the same cell. The relatively low efficiency of cotransformation of multiple DNA molecules is one of the major challenges for large scale genome engineering applications, such as multiplex genome editing and genome-scale engineering.
Accordingly, Bao et al. followed a different experimental design, where a 100-bp HDR template was fused to the 5'-end of the crRNA sequences [23] . Such a homology integrated CRISPR/Cas (HI-CRISPR) system (HDR donor-crRNA design) enabled multiplexed knock-out of CAN1, ADE2, and LYP1 with efficiencies up to 87%. In addition, ATF2, GCY1, and YPR1 involved in an artificial hydrocortisone biosynthetic pathway were disrupted with an efficiency of 100%. Notably, HDR donor-gRNA design was found to achieve similar genome editing efficiencies [24] .
Recently, there is a growing interest in engineering polyploid industrial yeast strains, which have been demonstrated to be more productive and resistant to harsh industrial conditions.
However, the presence of several copies of the chromosomes becomes the major hurdle: during CRISPR/Cas based genome editing process, double-strand breaks can be repaired by the provided DNA donor (edited) or the other copies of the chromosome (non-edited). Therefore, much lower gene knock-out efficiency was generally observed for industrial strains [20, [25] [26] [27] . For example, the disruption of a single gene (URA3, TRP1, LEU2, or HIS3) with an efficiency between 15-60% was reported in the triploid industrial yeast strain ATCC 4124 [26] . Presumably, with increased gRNA expression levels, it is possible to introduce double-strand breaks to all copies of the chromosome simultaneously, which can only be repaired with the provided DNA donors to create the desirable genomic modifications. In order to increase gRNA abundance, Ryan et al. fused hepatitis delta virus (HDV) ribozyme at the 5'-end of gRNA. Such an HDV-gRNA expression strategy increased multiplex genome editing in a diploid yeast strain, where two genes (URA3 and LYP1) and three genes (URA3, LYP1, and COX10) were disrupted with an efficiency of 43% and 19%, respectively.
Nevertheless, the deletion efficiency of URA3 and LYP1 dropped from 43% to 3.5% for gRNA expression without HDV [20] . Lian et al. 
CRISPR mediated gene knock-in
With the application of CRISPR/Cas, marker-free integration of multiple genes or metabolic pathways is possible by simply re-designing the HDR donors. DiCarlo et al.
demonstrated that the KanMX cassette encoding G418 resistance can be integrated into the CAN1 locus with nearly 100% efficiency [17] .
From the viewpoint of metabolic engineering, the integration sites in the chromosome must be carefully considered (Fig. 1E ), since they can affect the stability and transcriptional activity of the foreign gene expression cassettes. Jessop-Fabre et al. selected the previously characterized loci flanked by highly expressed essential genes and developed the EasyClone-MarkerFree vector toolkit for marker-less integration [28] . [29] .
Recently, Reider et al. further developed a more comprehensive toolkit to program gene expression in S. cerevisiae [30] . The toolkit includes 23 Cas9-gRNA plasmids (each for a specific integration site), 37 promoters of various strengths, and 10 protein-localization, degradation, and solubility tags. The applicability of this toolkit was demonstrated by the construction of a taxadiene producing yeast strain. This toolkit was used to diagnose and solve an issue with functional expression of taxadiene synthase, resulting in a 25-fold improvement in taxadiene production.
CRISPR mediated multiplex genome integration was also demonstrated by multi-copy integration of metabolic pathways into the delta sites, the repeated retrotransposon element in the yeast genome [31, 32] . A combined xylose utilization and (R,R)-2,3-butanediol (BDO) biosynthetic pathway (a total size of 24 kb) was integrated into the yeast genome in up to 18 copies, leading to direct BDO production from xylose.
If the heterologous genes or pathways are integrated into the coding sequences (CDS),
gain-of-function and loss-of-function can be achieved simultaneously (Fig. 1F ). For example, Tsai et al. constructed a xylose-fermenting strain by integrating two copies of the xylose utilization pathway (XYL1, XYL2, and XYL3 encoding xylose reductase, xylitol dehydrogenase, and xylulokinase, respectively) into PHO13 and ALD6 loci with efficiencies of 25-100% [33] . The simultaneous introduction of the heterologous pathway and disruption of the endogenous genes enabled the xylose utilization rate comparable to that of a previously extensively engineered and evolved yeast strain (SR8).
A more versatile genome engineering strategy was demonstrated by Cas9-facilitated multiloci integration of in vivo assembled DNA parts (CasEMBLR), in which gene deletion and integration and in vivo assembly of DNA parts were combined ( Fig. 1G ) [34] . As a proof-of-concept, one-step assembly and integration of all three five-part gene expression cassettes (upstream homology arm, promoter, CDS, terminator, and downstream homology arm) of CrtYB, CrtI and
CrtE into ADE2, HIS3, and URA3 loci resulted in a marker-free engineering efficiency of 31%. lpd, and pdhA) with simultaneous deletion of both ACS1 and ACS2 [22] . Horwitz et al. in vivo assembled and integrated an 11-gene muconic acid biosynthetic pathway (24 kb) into the GAL80, HO, and ARO1 loci, although the efficiency was reported to be rather low (4%) [35] .
Besides on and off state engineering, knock-in of promoters with different strengths can also be used to precisely regulate endogenous gene expression levels. For example, Jakociunas et al. knocked in a weak promoter without upstream activating sequences to down-regulate the expression of ERG9 to increase the production of mevalonate in yeast [21] . Xu et al. knocked in four promoters with various strengths (RPS13p, HFF1p, TEF2p, and CCW12p) to study the effect of TAL1 expression levels on xylose metabolism [36] . In addition, soluble expression tags and degradation tags could be knocked into CDS to regulate protein abundance and stability [30] .
Cas9 orthologs for genome editing in yeast
Notably, all the previous mentioned studies were based on Cas9 from S. pyogenes (SpCas9).
An important limitation metabolic engineers are facing is the dependence on the protospacer adjacent motif (PAM, NGG). In order to have more flexible designs, novel Cas9 orthologs and engineered SpCas9 variants with different PAM requirement have been characterized, such as the Cas9 from Neisseria meningitides (NmCas9, NNNNGATT) [37, 38] , Streptococcus thermophiles (St1Cas9, NNAGAAW) [38, 39] , and Staphylococcus aureus (SaCas9, NNGRRT) [35, 39] , Cpf1 [40] from Lachnospiraceae bacterium ND2006 (LbCpf1, TTTN) and Acidaminococcus sp. BV3L6 (AsCpf1, TTTN), as well as SpCas9-VQR (NGAN or NGNG), SpCas9-EQR (NGAG), and SpCas9-VRER (NGCG) [39] . Although all the above mentioned Cas9 orthologs have been functionally characterized in mammalian cells, Lian et al. found that NmCas9 and AsCpf1 were not functional and LbCpf1 and St1Cas9 must be tagged with NLS (nuclear localization signal) at both ends to show endonuclease activities in yeast [24] . In another study, Verwaal et al. codonoptimized AsCpf1 and LbCpf1 for expression in S. cerevisiae, both of which were functionally expressed for genome editing with a comparable efficiency with SpCas9 [41] .
Base editors: genome editing without DNA cleavage
Different from the nuclease-based CRISPR systems, base editors enabled targeted genome editing without introducing DNA double-strand breaks [42] . Base editors were designed by fusing catalytically defective Cas9 (dCas9 or Cas9 nickase) with a cytidine deaminase, which deaminated deoxycytidine to deoxyuridine and resulted in C•G to T•A conversion. Targeted DNA mutagenesis using base editors has been demonstrated in yeast [43] , plant [44] , and mammalian cells [45] . Most recently, Gaudelli et al. further developed adenine base editors that mediated the conversion of A•T to G•C, expanding the scope of base editing [46] . Taken together, all four transitions (C to T, A to G, T to C, and G to A) in genome engineering are possible using base editors. Although the efficiency of gene disruption was reported to be lower than those nuclease-based systems, base editors demonstrated significantly reduced off-targeting and cellular toxicity [43, 45, 46] . Therefore, base editors should be powerful synthetic biology tools for genome editing of some bacteria and non-conventional yeasts, where HDR efficiency is low and/or CRISPR nucleases are toxic.
CRISPR for transcriptional regulation
Besides precision genome engineering, transcriptional regulation is also a powerful approach and often adopted for metabolic engineering. The most commonly used approach to regulate endogenous gene expression is to replace the native promoter with that of desired strength.
However, homologous recombination based promoter replacement is labor and time intensive and suffers from low throughput. The hallmark discovery that nuclease deficient Cas9 (dCas9) retained its gRNA binding and sequence-specific DNA targeting activity opens a new door for transcriptional regulation of endogenous genes (Fig. 1B ) [13] . Through recruiting the corresponding effector domains, dCas9 based artificial transcriptional factors can activate or repress nearly every gene in the genome. Notably, the activator or repressor domains can either be directly fused with dCas9 ( Fig. 1B, upper panel) or bound to gRNA scaffolds via aptamer-RNA binding protein interactions (Fig. 1B, bottom panel) .
Qi et al. were the first to apply dCas9 for RNA-guided transcriptional reprogramming, demonstrating that dCas9 targeted binding functioned as a physical block of transcription initiation and elongation [15] . Different with the prokaryotic system, a repressor domain such as MXI1 or KRAB is necessary for maximal CRISPRi. When targeting the endogenous TEF1 promoter, dCas9
alone resulted in 18-fold repression, which was increased to 53-fold with the MXI1 domain [47] .
Although MXI1 is commonly used, this mammalian repressor domain may not be optimal for CRISPRi efficiency was further enhanced by fusing multiple repressor domains together [24] . The engineered CRISPRi was adopted to repress the expression of ERG9 and MNN9 for improved lycopene production and heterologous protein secretion, respectively.
Likewise, dCas9 can be fused to transcriptional activator domains to allow for RNA-guided activation of target genes. For CRISPRa, several transcription activator domains have been used, such as VP64, p65AD, and Rta. In addition, the rationally designed tripartite activator, VP64-p65-Rta (VPR), resulted in dramatically improved CRISPRa efficiency in a broad range of organisms, including S. cerevisiae [48] . For example, dCas9-VPR resulted in 38 and 78-fold activation of the HED1 promoter and GAL7 promoter, respectively, while dCas9-VP64 with only 9 and 14-fold activation of the same promoters. To achieve maximal CRISPRa, Lian et al. tested all possible combinations of 4 nuclease-deficient CRISPR proteins (dSpCas9, dSaCas9, dSt1Cas9, and dLbCpf1) and 3 activation domains (VP64 (V), VP64-p65AD (VP), and VP64-p65AD-Rta (VPR)).
Interestingly, the optimal activation domain was determined to be CRISPR protein dependent: for dSpCas9, stronger activation domain resulted in more efficient CRISPRa (VPR>VP>V); for dSt1Cas9, the order was completely reversed (V>VP>VPR); while for dLbCpf1, the medium strength activation domain worked the best (VP>VPR>V) [24] . Based on the activation levels and flexibility of gRNA design, dSpCas9-VPR and dLbCpf1-VP were determined to be optimal for CRISPRa in yeast.
Instead of fusing activator or repressor domains to dCas9 directly, Zalatan et al. undertook a different approach termed as 'scaffold RNA' (scRNA) to achieve targeted upregulation and downregulation [16] . scRNA was constructed with additional protein recruitment capabilities by introducing an aptamer (RNA hairpin sequences, such as MS2, PP7, and Com) to the 3' end of gRNA. The activator or repressor domains were then recruited via the interaction of aptamer-RNA binding proteins. Interestingly, gene activation using scRNA with VP64 was elevated 20 to 50-fold, much higher than that with dCas9-VP64 [16] . In addition, several aptamers could be combined in a single scRNA to achieve even higher transcriptional reprogramming.
Multi-functional CRISPR system for combinatorial metabolic engineering
Metabolic engineering of an optimal microbial cell factory often requires overexpression, knock-down, and knock-out of multiple gene targets. As mentioned above, nearly all the functional modules needed for metabolic engineering have been incorporated into the CRISPR toolkit in yeast.
Therefore, there is a growing interest in combining several CRISPR modules in the same cell to enable different modes of genetic manipulation of multiple targets. Since the host genome can be manipulated via plasmid-borne gRNAs ( Fig. 2A) , multi-functional CRISPR systems can be used for combinatorial optimization of various metabolic engineering targets in a modular, parallel, and high throughput manner.
SWITCH
Vanegas et al. combined Cas9 based genome editing and dCas9 based transcriptional regulation [49] . The resulting SWITCH system allowed the S. cerevisiae strain to alternate between a genetic engineering state and a pathway control state (Fig. 2B) , with naringenin production as a case study. First, Cas9 was used for marker-less integration of a multigene naringenin biosynthetic pathway into the chromosome. By transforming a Cas9 self-targeting gRNA plasmid and dCas9 fragment, the Cas9 expression cassette was replaced by that of dCas9. In other words, the cells switched from the genome editing state to a pathway control state. Then naringenin production was increased through dCas9-mediated repression of an essential gene TSC13 to prevent the formation of by-product. Nevertheless, only one genetic modulation is possible at a time, and the switch from pathway control state back to genome editing state required re-introduction of Cas9 expression cassette with the use of a selection marker.
STEPS: Systematically test enzyme perturbation sensitivities
In addition to on/off states of gene expression, graded modulation of gene expression levels has been found to be equally important for metabolic engineering. Deaner and Alper established a rapid method for fine-tuned and graded expression of pathway enzymes via dCas9-VPR or dCas9-MXI1 regulation [50] . By selecting gRNAs to target different regions of a promoter, a dynamic range of gene expression was demonstrated from near silence to strong overexpression in a gRNA coded manner. STEPS was used to quantify rate limiting enzymes for metabolic engineering applications. For example, STEPS was used to identify pathway bottlenecks in glycerol biosynthesis, 3-dehydroshikimate production, and xylose catabolism, through which the production of glycerol and 3-dehydroshikimate was increased by 5.7-fold and 7.8-fold, respectively. However, due to the cross-talk between dCas9-VPR and dCas9-MXI1, the activation and repression gRNA libraries should be tested in two separate strains (Fig. 2C) . Although STEPS could be iterated to explore the synergistic interaction among gain-of-function and loss-of-function targets, one target with a single mode modulation was obtained in each round of screening.
Therefore, STEP may not be an ideal synthetic biology tool for engineering complex phenotypes, as demonstrated in the xylose catabolism case that no individual target was found to enhance xylose utilization.
dCas9-VPR as a dual-mode activator/repressor
To achieve simultaneous activation and repression of multiple targets within a cell, Deaner et al. repurposed the dCas9-VPR activator to act as a dual-mode activator/repressor [51] . It was based on the interesting finding that dCas9-VPR could block transcription initiation and elongation (similar as CRISPRi) at the core promoter and within the CDS while serving as a transcriptional activator upstream of the core promoter. In other words, such a dual-mode transcriptional reprogramming was solely dependent on the target position at the gene expression cassette. By "stepping" dCas9-VPR within the promoter region and CDS, graded activation and repression could be achieved to allow precise control of multiple genes to different expression levels (Fig.   2D ). The authors demonstrated the multiplex modulation of 4 native genes (NDE2 and CYC1 for activation and GPD1 and TDH3 for repression) using a single dCas9-VPR activator. Thus, dual mode dCas9-VPR provided a single protein based approach for combinatorial modulation of gene expression in yeast. Nevertheless, application of this dual-mode dCas9-VPR system in metabolic engineering has not been explored yet.
CRISPR RNA scaffold
As mentioned above, scRNA recruited its effector domain via aptamer-RNA binding protein interaction, i.e. MS2 to recruit MCP-VP64 for CRISPRa and Com to recruit Com-MXI1
for CRISPRi. When orthogonal aptamer and RNA binding protein pairs are used, such a system allows for activation and repression of various genes simultaneously (Fig. 2E) . As a proof-ofconcept, Zalatan et al. tested the scRNA system for redirecting the metabolic fluxes of the violacein biosynthetic pathway (VioA, VioB, VioE, VioC, and VioD) in yeast by orthogonally controlling the expression levels of VioD and VioC. By testing different scRNA combinations, the authors were able to detect the formation of all possible intermediates of the violacein pathway as the major products. Interestingly, although orthogonal transcriptional regulation was developed using scRNA, the use of such system for CRISPRi was only demonstrated in mammalian cells and unmodified gRNA (without aptamer and RNA binding protein to recruit a repressor domain) was used for CRISPRi in yeast [16] . In another study, Jensen et al. reported the use of scRNA for transcriptional reprogramming in yeast. With scRNAs activating HMG1 and HMG2 while simultaneously repressing ERG9, the intensity of the carotenoid pigmentation was increased [52] .
Tri-functional CRISPR
To address the challenges in combinatorial metabolic engineering in yeast cell factory development, Lian et al. developed an orthogonal tri-functional CRISPR system that combines transcriptional activation, transcriptional interference, and gene deletion (CRISPR-AID) in the same cell [24] . The tri-functional CRISPR-AID system was based on three orthogonal CRISPR proteins, one nuclease-deficient CRISPR protein fused with an activation domain for transcriptional activation (CRISPRa), a second nuclease-deficient CRISPR protein fused with a repression domain for transcriptional interference (CRISPRi), and a third catalytically active CRISPR protein for gene deletion (CRISPRd) (Fig. 2F) . Through optimization of CRISPR proteins and the corresponding effector domains, 5-fold activation of a red fluorescent protein, 5-fold interference of a yellow fluorescent protein, and >95% deletion of an endogenous gene could be achieved simultaneously. As a proof-of-concept metabolic engineering study, CRISPR-AID was adopted to increase β-carotene production via simultaneous upregulation of HMG1, downregulation of ERG9, and deletion of ROX1. Then CRISPR-AID was applied for combinatorial optimization of several metabolic engineering targets (14 targets for CRISPRa, 17
targets for CRISPRi, and 5 targets for CRISPRd) to enhance the expression and display of a recombinant protein on the yeast surface. CRISPR-AID was particularly useful in exploring the synergistic interactions among gain-of-function and loss-of-function modifications, such as the synergy of PDI1 upregulation and MNN9 downregulation for recombinant protein secretion and surface display [24] . Overall, CRISPR-AID enables perturbation of the metabolic and regulatory networks in a modular, parallel, and high throughput manner and will be a valuable and powerful synthetic biology tool for metabolic engineering of complex phenotypes.
Strategies for multiplex gRNA expression
Functional expression of gRNA is crucial for CRISPR based genome engineering. With the development of multiplex genome engineering and multi-functional CRISPR systems, the design and expression of multiple gRNAs becomes particularly important. In terms of the cost and flexibility for metabolic engineering applications, it is desirable to clone multiple gRNAs on the same plasmid, preferably in one expression cassette.
The most common strategy is to use an RNA polymerase III (Pol III) promoter, such as the SNR52 promoter [17] and the tRNA promoters [20] , to drive the expression and maturation of gRNA or crRNA (Fig. 3A) . It was found that the fusion of a ribozyme sequence at the 5'-end (Fig. 3B) increased the abundance of gRNA and accordingly genome editing efficiency. It is also possible to fuse the HDR donor (100 bp) at the 5'-end of crRNA (Fig. 3C) or gRNA (Fig. 3D) , which seems to not affect gRNA expression and genome editing efficiency [23, 24] .
Both ends of the gRNA molecule must be precisely defined to create a functional Cas9/gRNA complex. Thus, the presence of 5'-UTR and 3'-UTR makes Pol II non-ideal for direct expression of functional gRNA(s). Fortunately, several strategies have been designed and developed to overcome this limitation. For example, gRNA sequences can be flanked by ribozyme sequences (ribozyme-gRNA-ribozyme, RGR, Fig. 3E ) [51, 53] and Csy4 (sequence specific ribonuclease) recognition sequences (Fig. 3F ) [24] . In all the cases, the terminal RNA sequences were processed to release the mature gRNA sequences. It was found that expression from the Pol II system with ribozymes increased the net amount of gRNA by ~4-fold relative to the Pol III SNR52 promoter, leading to a significantly improved CRISPR efficiency [51] .
In order to express multiple gRNAs, a canonical method is to put several gRNA expression cassettes on the same plasmid. For example, individual gRNA cassettes were constructed in the first step and then multiple gRNA expression cassettes were pierced together using Golden-Gate assembly [24] or Gibson assembly [22] (Fig. 3G) . Such a two-step cloning strategy can be tedious and time consuming, and a more efficient and economical way is to put several gRNAs or crRNAs on the same expression cassette. Bao et al. followed the bacterial crRNA array design, with the whole array placed under the control of a Pol III promoter (Fig. 3H ) [23] . Nevertheless, since Pol III promoters are generally used for generating short transcripts, the number of fully transcribed gRNAs can be rather limited and a growing interest is to express multiple gRNAs using Pol II promoters. By flanking each gRNA sequence with ribozyme sequences (Fig. 3I ) and Csy4 recognition sequences (Fig. 3J) , the full sequence will be transcribed by Pol II promoter and processed to release mature gRNAs. The ribozyme sequences will be self-processed and at least 4 gRNAs have been successfully expressed using this Pol II-RGR system [51] . Csy4 co-expression is required to process the Pol II-Csy4-gRNA arrays and at least 3 gRNAs can be fully transcribed and processed [24] . Since the Csy4 recognition sequence is rather short (20 bp), it makes the DNA synthesis and cloning of multiple gRNAs much easier.
Computational gRNA design
Given the vastly different requirements for guide RNAs for each specific application and the complexity of those requirements, computational tools are crucial for designing gRNAs to target the best regions to perform the function of interest. There are many aspects where computational tools are especially important such as estimating the efficiency and specificity of gRNAs as well as generating large-scale gRNA libraries. Specificity of binding to a particular locus and the efficiency of binding are difficult to determine manually without good computational programs and algorithms. Moreover, selection of the loci to be targeted which can perform the function of interest while having good specificity and efficiency is very challenging. In some applications, a large number of guides need to be designed to target many loci in the genome and the best ones have to be chosen by a ranking algorithm which is close to impossible to accomplish manually. Many computational gRNA design tools have been developed, but they have vastly different functionalities ranging from versatile PAM sequences to sophisticated algorithms for calculating specificity and efficiency. A list of computational programs to design gRNAs for yeast genome engineering has been summarized in a most recent review [18] .
Specificity
Specificity of gRNAs is especially important because off-targets can considerably damage the genome and cause unknown changes [54] . If an unintended locus is accidentally cleaved, it can either kill the cell or cause unknown genomic reconfiguration, causing unexpected outcomes. This can happen in the cells where the locus of interest has already been cleaved and repaired and there are still many guides and Cas9 proteins present searching for the next locus to cleave. Specificity of gRNAs is mostly determined by the similarity of the designed gRNA to other locations in the genome, which is most important in larger genomes but still crucial in organisms with smaller genomes like S. cerevisiae. Most of the algorithms for determining the specificity of any given gRNA find the number of locations in the genome whose sequence shares high homology with the guide. For example, CRISPRdirect [55] returns the number of 8, 12 and 18-mers in the genome that match each guide and the user can estimate the specificity of the guides based on the number of these matches. Other tools like CHOPCHOP [56] enable the user to choose between different criteria such as the number of mismatches in the protospacer [57] or the protospacer seed region [10] . Although in most cases off-targeting is undesirable, in some cases guides can be unspecific by purpose. The unspecificity of guide sequences can be used to target multiple genes with similar sequences, potentially disrupting slightly different copies of genes in the genome by finding guides that are most likely to target all of the copies [58] .
Efficiency
The binding efficiency of gRNAs is of great importance when choosing the gRNA for targeting the genome since all of the desired functions (transcriptional activation and interference and gene deletion) depend on the efficient binding of the Cas9 protein to the target. There are many studies that have experimentally determined the DNA motifs that increase the binding efficiency of different Cas9 proteins. However, since most of the CRISPR targeting is carried out using the SpCas9, the most extensive set of rules are available for this particular Cas9. For example, CHOPCHOP [56, 59] covers a wide array of scoring systems for estimation of efficiency. These scoring criteria were obtained from studies involving SpCas9 with NGG PAM sequence that have found motifs next to the PAM that affect the binding [60, 61] and other sequence specific scoring systems [62] . There are also more targeted scoring systems for more specific applications [63] where the scores have only been obtained and validated in certain genomes such as the Mus musculus (mm10) and the Homo sapiens (hg19). However, there has been a growing interest in finding a species-independent model to predict the efficiency and activity of guide RNAs. A recently developed tool called sgRNA Scorer 2.0 is able to predict the activity for Cas9 from multiple sources [64] . A machine learning algorithm, Support Vector Machine, was trained with efficiency data obtained from SpCas9 and found to be remarkably accurate in predicting the activity of other Cas9 and non-Cas9 systems.
Large-scale gRNA design
Another area where computer aided gRNA design is especially important is large-scale or genome-wide library construction. These libraries are often as large as hundreds of thousands of guides and their manual design is highly impractical. Although there are many software packages that can design single guide sequences, there are a relatively few free software packages available for large-scale design because it is computationally intensive and a significant amount of computational power is required to sustain the ever-growing demand for gRNA design. For example, one of the first and most widely used CRISPR design websites (http://crispr.mit.edu/)
obtains the chromosomal region of interest from the user and sends the results via email with a few minutes delay due to the high demand on their servers. Using these tools for targeting thousands of genes and loci on the genome is prohibitively slow. Fortunately, the authors of CRISPRdirect [55] have offered a generally fast solution to the CRISPR community where an Application Program Interface (API) can be easily written to communicate with their servers and get the gRNA results within seconds of submission. This code snippet can be included in any program and allows for the flexible and large-scale design of gRNAs. This is one of the most convenient ways of designing large scale guide RNAs for SpCas9 with three base PAM sequences.
In a different solution, all the guides for targeting the genes in multiple organisms using Cpf1 are stored in a database and the user can decide on the criteria to sort the guides. The sorted guides for one gene or a set of genes can then be exported for targeting the genes of interest [65] . However, due to the inflexibility of CRISPRdirect and Cpf1 database and that their scope is mostly limited to SpCas9 and Cpf1, they cannot be used for all applications. The authors of CHOPCHOP software, however, have made its source code public (https://bitbucket.org/valenlab/chopchop) and it can be used to run large-scale design of gRNAs for a variety of different Cas9 and Cpf1 nucleases as well as target genomes. This flexibility allows the users to even use custom genomes as an input to the software and design specific guides to target different loci in that genome.
Conclusion and Future Perspectives
The CRISPR/Cas9 technology has advantages over conventional genome engineering, allowing multiple genomic edits simultaneously in a selection marker-free manner. This review summarizes the recent development of CRISPR based synthetic biology tools for genome editing and transcriptional regulation, with a focus on their metabolic engineering applications in S.
cerevisiae. Particularly, we highlight the design and implementation of multi-functional CRISPR systems for combinatorial metabolic engineering.
For practical metabolic engineering applications, it is also important to control the function of the CRISPR system. Inducible expression (tetracycline or galactose inducible promoters) of both Cas9 [16, 66] and gRNA [51] have been reported. In addition, CRISPR-based cell-cell communication system [67] and genetic circuits [68] have been developed in yeast. In combination with the multi-functional CRISPR system, this should allow for the timely and quantitative reprogramming of the metabolic and regulatory networks for the construction and optimization of yeast cell factories.
Although yeast is one of the most well studied microorganisms, there is still a lack of a clear and thorough understanding of the whole metabolic and regulatory networks. In previous metabolic engineering efforts, some unknown or unrelated targets increased the desired phenotype the most [69, 70] . Therefore, genome-scale metabolic engineering is demanded to cover all the possible metabolic engineering targets. Since HDR is the dominant mechanism to repair DNA double-strand breaks in yeast, the chance to introduce gRNA and the corresponding linear DNA donor into the same yeast cell is extremely low at the whole genome scale. The HI-CRISPR design, where the HDR donor and gRNA were physically linked, provides a possible solution [23, 71, 72] .
For example, Bao et al. created a genome-wide knockout library using CRISPR/Cas9 and homology-directed repair assisted genome-scale engineering (CHAnGE) [71] . CHAnGE was used to evolve yeast strains with improved furfural and acetic acid tolerance. Such a design was also used for genome-scale engineering in E. coli [72] . More importantly, by combining genome-scale engineering and a multi-functional CRISPR system, the most comprehensive library that can control the expression of any single gene in the yeast genome to various levels can be created for yeast cell factory development. One essential component missing is a computational program to design efficient gRNAs for CRISPRa and CRISPRi at the whole genome scale. Most of the currently developed computational tools were developed to design gRNAs for gene deletion, with the guide sequence (i.e. on-target score and off-target score) as the major consideration.
Nevertheless, the binding position related to transcriptional factor binding and nucleosome occupancy status is at least equally important for CRISPRa and CRISPRi. Therefore, the development of robust algorithms that can predict and design efficient gRNAs for CRISPRa and
CRISPRi at single nucleotide level will be highly desirable.
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